Adage Capital Partners’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,300,000
| Closed | -$33.5M | – | 862 |
|
|
2024
Q4 | $33.5M | Buy |
4,300,000
+233,966
| +6% | +$1.82M | 0.06% | 304 |
|
|
2024
Q3 | $43.9M | Sell |
4,066,034
-182,854
| -4% | -$1.97M | 0.08% | 254 |
|
|
2024
Q2 | $35.8M | Buy |
4,248,888
+2,915,555
| +219% | +$24.6M | 0.07% | 290 |
|
|
2024
Q1 | $8.96M | Buy |
+1,333,333
| New | +$8.96M | 0.02% | 617 |
|
|
2023
Q4 | – | Sell |
-1,036,069
| Closed | -$10.1M | – | 872 |
|
|
2023
Q3 | $10.1M | Sell |
1,036,069
-100,000
| -9% | -$975K | 0.02% | 559 |
|
|
2023
Q2 | $13.5M | Sell |
1,136,069
-250,544
| -18% | -$2.97M | 0.03% | 507 |
|
|
2023
Q1 | $15M | Buy |
1,386,613
+350,000
| +34% | +$3.78M | 0.03% | 510 |
|
|
2022
Q4 | $12M | Sell |
1,036,613
-110,037
| -10% | -$1.27M | 0.03% | 592 |
|
|
2022
Q3 | $17.1M | Sell |
1,146,650
-80,000
| -7% | -$1.19M | 0.04% | 470 |
|
|
2022
Q2 | $11.1M | Buy |
+1,226,650
| New | +$11.1M | 0.03% | 645 |
|